Roivant Sciences Ltd at Cantor Global Healthcare Conference Transcript - Thomson StreetEvents

Roivant Sciences Ltd at Cantor Global Healthcare Conference Transcript

Roivant Sciences Ltd at Cantor Global Healthcare Conference Transcript - Thomson StreetEvents
Roivant Sciences Ltd at Cantor Global Healthcare Conference Transcript
Published Sep 03, 2025
12 pages (7349 words) — Published Sep 03, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ROIV.OQ presentation 3-Sep-25 12:35pm GMT

  
Brief Excerpt:

...Unidentified Participant Start with some of the key priorities for the company to levels that expectations for the next, one to two years. Matthew Gline ...

  
Report Type:

Transcript

Source:
Company:
Roivant Sciences Ltd
Ticker
ROIV.OQ
Time
12:35pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Roivant Sciences Ltd at Morgan Stanley Global Healthcare Conference Summary – 2025-09-08 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 8-Sep-25 9:35pm GMT

Roivant Sciences Ltd at Morgan Stanley Global Healthcare Conference Transcript – 2025-09-08 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 8-Sep-25 9:35pm GMT

Roivant Sciences Ltd at Wells Fargo Healthcare Conference Summary – 2025-09-04 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 4-Sep-25 7:00pm GMT

Roivant Sciences Ltd at Wells Fargo Healthcare Conference Transcript – 2025-09-04 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 4-Sep-25 7:00pm GMT

Roivant Sciences Ltd at Cantor Global Healthcare Conference Summary – 2025-09-03 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 3-Sep-25 12:35pm GMT

Roivant Sciences Ltd Q1 2025 Earnings Call Summary – 2025-08-11 – US$ 54.00 – Edited Brief of ROIV.OQ earnings conference call or presentation 11-Aug-25 12:00pm GMT

Roivant Sciences Ltd Q1 2025 Earnings Call Transcript – 2025-08-11 – US$ 54.00 – Edited Transcript of ROIV.OQ earnings conference call or presentation 11-Aug-25 12:00pm GMT

Roivant Sciences Ltd Investor Event on Brepocitinib Summary – 2025-06-17 – US$ 54.00 – Edited Brief of ROIV.OQ corporate analyst meeting</ 17-Jun-25 5:00pm GMT

Roivant Sciences Ltd Investor Event on Brepocitinib Transcript – 2025-06-17 – US$ 54.00 – Edited Transcript of ROIV.OQ corporate analyst meeting</ 17-Jun-25 5:00pm GMT

Roivant Sciences Ltd at Goldman Sachs Global Healthcare Conference Summary – 2025-06-10 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 10-Jun-25 11:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Roivant Sciences Ltd at Cantor Global Healthcare Conference Transcript" Sep 03, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-at-Cantor-Global-Healthcare-Conference-T16494299>
  
APA:
Thomson StreetEvents. (2025). Roivant Sciences Ltd at Cantor Global Healthcare Conference Transcript Sep 03, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-at-Cantor-Global-Healthcare-Conference-T16494299>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.